Author Details

Жукова, Людмила Григорьевна

Issue Section Title File
Vol 19, No 4 (2017) Articles Clinical and radiological evaluation the effectiveness of preoperative systemic therapy in different biological subtypes of breast cancer stages T1-3N0-1M0 PDF
(Rus)
Vol 19, No 4 (2017) Articles Soft tissue metastases of the gluteal region in HER2+ breast cancer: a clinical case PDF
(Rus)
Vol 20, No 1 (2018) Articles Ramucirumab therapy in patients with advanced gastric cancer: discussion of a case series PDF
(Rus)
Vol 20, No 1 (2018) Articles Dermatomyositis and polymyositis in breast cancer patients: a case reports PDF
(Rus)
Vol 20, No 2 (2018) Articles Optimal duration of adjuvant trastuzumab therapy in patients with HER2-possitive early breast cancer: whether the problem is resolved? PDF
(Rus)
Vol 20, No 2 (2018) Articles Ribociclib in 1st line HR+ breast cancer treatment PDF
(Rus)
Vol 21, No 2 (2019) Articles The potential of using eribulin in patients with breast cancer, associated with brain metastasis: the scientific background and the Russian clinical experience PDF
(Rus)
Vol 21, No 1 (2019) Articles Efficacy and safety of eribulin in HER2-negative metastatic breast cancer: the results of long-term experience in real clinical practice in Russia PDF
(Rus)
Vol 21, No 3 (2019) Articles Immunotherapy in combination with chemotherapy in triple-negative breast cancer - the first “target” therapy for the “target” patients’ population PDF
(Rus)
Vol 21, No 3 (2019) Articles The efficacy of neoadjuvant chemotherapy and survival in older patients with stages II to III triple-negative breast cancer PDF
(Rus)
Vol 22, No 4 (2020) CLINICAL ONCOLOGY The virtual forum on the diagnosis and treatment of PIK3CA-mutated metastatic breast cancer. October 16th, 2020. Event review PDF
(Rus)
Vol 22, No 4 (2020) CLINICAL ONCOLOGY Improving early breast cancer treatment: the role of granulocyte colony-stimulating factor PDF
(Rus)
Vol 23, No 1 (2021) CLINICAL ONCOLOGY Breast cancer PDF
(Rus)
Vol 23, No 1 (2021) CLINICAL ONCOLOGY Analysis of the efficacy and safety of eribulin therapy in patients with HR+/HER2- metastatic breast cancer pretreated with CDK4/6 inhibitors in real Russian practice PDF
(Rus) PDF
(Eng)
Vol 23, No 1 (2021) CLINICAL ONCOLOGY Antiangiogenic therapy for breast cancer with triple negative phenotype PDF
(Rus)
Vol 23, No 4 (2021) CLINICAL ONCOLOGY The consensus on the prevention and correction of rash in patients with HR+ HER2- metastatic breast cancer treated with alpelisib PDF
(Rus)
Vol 24, No 3 (2022) CLINICAL ONCOLOGY Antitumor response and quality of life: is there a need to sacrifice? Clinical observation: long-term and safe control of the disease using a combination of ribociclib with letrozole. Case report PDF
(Rus)
Vol 25, No 3 (2023) CLINICAL ONCOLOGY Resolution of the advisory board on the topic: “The place of entrectinib in the treatment of adult patients with NTRK-fusion positive solid tumors” PDF
(Rus)
Vol 24, No 4 (2022) CLINICAL ONCOLOGY Real-world efficacy of the first line therapy with prolgolimab in patients with metastatic melanoma: interim results of the FORA (FOrteca Real practice Assessment) observational study PDF
(Rus)
Vol 25, No 1 (2023) CLINICAL ONCOLOGY The effect of CDK4/6 inhibitors on the overall survival in patients with advanced HR+/HER2- BC in the entire population and in special clinical subgroups of unfavorable prognosis: A review PDF
(Rus)
Vol 25, No 2 (2023) CLINICAL ONCOLOGY The role of neoadjuvant chemotherapy in patients with primary resectable pancreatic cancer: A retrospective cohort study PDF
(Rus)
Vol 25, No 4 (2023) CLINICAL ONCOLOGY How a significant increase in survival in pancreatic cancer is achieved. The role of nutritional status and supportive care: A review PDF
(Rus)
Vol 26, No 1 (2024) Articles Final data on the efficacy of the FORA study (FOrteca Real practice Assessment): a multicenter prospective observational study on the real-world efficacy of prolgolimab in patients with metastatic melanoma in Russia PDF
(Rus)
Vol 26, No 1 (2024) Articles Safety and efficacy of ribociclib in combination with letrozole in an extended population of patients with HR+/HER2- advanced breast cancer: analysis of data from a subgroup of patients from Russia in the phase lllb CompLEEment-1 study PDF
(Rus)

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies